
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
29 November 2002:
Zealand Pharma announces successful Phase I trials for ZP120 in acute heart failure
18 September 2002:
Zealand Pharma reports successful phase I/IIa trial with ZP10 in type 2 diabetes patients
12 June 2002:
Zealand increases focus on Gap Junctions
4 April 2002:
Zealand in Clinical Trials with Aquaretic Compound
Home Legal Disclaimer Updated: 27.7.2010